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Abstract: A role for vitamin D in the regulation of immune function was first proposed 
after the identification of Vitamin D Receptors in lymphocytes. It has since been recognized 
that the active form of vitamin D, 1α,25(OH)2D3, has direct affects on naïve and activated 
helper T cells, regulatory T cells, activated B cells and dendritic cells. There is a growing 
body of literature linking vitamin D (serum 25(OH)D, oral intake and surrogate indicators 
such as latitude) to various immune-related conditions, including allergy, although the 
nature of this relationship is still unclear. This review explores the findings of 
epidemiological, clinical and laboratory research, and the potential role of vitamin D in 
promoting the inappropriate immune responses which underpin the rise in a broad range of 
immune diseases.  
Keywords: vitamin D; 25(OH)D; helper T cells; allergy; vitamin D receptor; immune system 
 
1. Introduction 
Vitamin D is a secosteroid obtained either through endogenous production in the skin with exposure 
to UVB radiation, or from dietary sources. Within the body vitamin D acts as a hormone and is well 
recognized for its role in calcium and phosphorus homeostasis and skeletal health. We now know that 
all tissues in the body posses receptors for the active form of vitamin D, 1,25-dihydroxyvitamin D 
(1α,25(OH)2D3) and it has recently been discovered that there are extrarenal tissues capable of 
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converting 25(OH)D to the active metabolite, including certain immune cells [1,2]. Aside from skeletal 
health, vitamin D has been associated with various cancers and autoimmune disorders [1] with 
evidence for a role in development and maintenance of lung structure and function [3–5]. It is this 
association with immune and airway function that provides the basis for the hypothesis that vitamin D 
may have direct links with asthma and allergic disease [6,7]. We aim to review the current evidence on 
vitamin D in relation to immune mechanisms and focus on the effect of pregnancy and early life 
exposure on allergy development. 
2. Vitamin D in the Context of the Allergy Epidemic 
The epidemic rise in allergic disease is now a major public health crisis, affecting more than 40% of 
the population in developed countries [8], with enormous impact on individuals, societies and health 
care systems [9]. The greatest burden of these diseases is during childhood, when the rapidly rising 
rates of disease are most evident [10]. As these younger generations reach maturity, it is possible that 
the impact of allergic disease will increase even further, especially as the same trends are emerging in 
developing countries undergoing lifestyle transition [10]. Furthermore, while the incidence of asthma 
appears to have reached a plateau in some developed nations, many of these regions are now facing a 
rise in food allergy in what appears to be a “second wave” of the allergy epidemic [11]. 
The rise in allergic disease is unequivocally linked to environmental and lifestyle factors associated 
with industrialization and progressive “Westernization”. A number of causative factors have been 
proposed for this including significant changes in lifestyle patterns, nutrient intake, exposure to 
microbial organisms and air pollution. However, most of these notions cannot individually explain the 
rise in disease. More recently variations in vitamin D status and intake has been implicated in   
allergy development and considered as one of a number of explanations for epidemiological and 
immunological associations.  
3. Is There Evidence of Vitamin D Deficiency with Lifestyle Change? 
During the industrial revolution the general population experienced a decrease in exposure to solar 
radiation secondary to more urban living, indoor occupation and atmospheric pollution [12]. This 
resulted in a dramatic and overt rise in vitamin D deficiency as rickets became endemic during this 
period. While the incidence of rickets has been largely reduced in Western countries through the use of 
dietary supplementation and UV exposure [12], the same societies continue to experience a high 
prevalence of sub-clinical vitamin D deficiency or insufficiency [13] that is likely related to indoor 
lifestyle habits with limited sun exposure. Although often not significant in terms of rickets or 
osteomalacia, it remains unknown what, if any, are the clinical outcomes of vitamin D insufficiency.  
A large percentage of human vitamin D requirements are provided via sun exposure [14] (at latitudes 
with adequate UVB exposure) which acts through stimulating the conversion of 7-dehydrocholesterol 
into D3 in the skin [15]. Lifestyle patterns and environments that do not facilitate adequate sun exposure 
(indoor occupation, “screen time” and active sun avoidance) predispose to inadequate vitamin D 
synthesis and status. Such populations are therefore reliant on dietary or supplemental sources of 
vitamin D; a factor that may be playing a role in the current allergy epidemic [16,17].  Nutrients 2012, 4  
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The global rise in adult and childhood obesity [18] may also be linked to lower serum 25(OH)D. 
Serum 25(OH)D is inversely associated with body mass index (BMI) and adiposity in children [19,20] 
and adults [21]. This association persists after adjusting for physical activity and dietary intake 
suggesting obesity is an independent risk factor for reduced serum 25(OH)D and supports the notion 
that vitamin D deficiency may follow from modern lifestyle change.  
An area for concern is the recognition of deficiency and insufficiency in pregnant women   
globally [22]. The developing foetus depends entirely on its mother for supply of 25(OH)D and poor 
maternal vitamin D status is reflected in the infant at birth [23]. In non-supplemented infants serum 
25(OH)D status tends to decrease over the first few months of life until sun exposure is increased and 
vitamin D-containing foods introduced into the diet. This raises the question of whether vitamin D 
status in utero and early life has effects on immune function and development of allergic disease. 
4. Immunological Basis for the Vitamin D Hypothesis: Potential Mechanisms 
4.1. Immune Cell Differentiation and Proliferation 
The role of vitamin D in regulation of the immune system was first recognized through the 
identification of Vitamin D receptors on peripheral blood mononuclear cells (lymphocytes) [2]. It has 
since been discovered that 1α,25(OH)2D3 has direct affects on activated helper T cells [24] as well as 
regulatory T cells, activated B cells and dendritic cells (DC) [25]. Differentiation of naive helper T cells 
into major subgroups of effector T cells (namely Th1 or Th2 cells) or into regulatory T cells is 
dependent on the microenvironment to which they are exposed [2]. Some studies have shown that the 
presence of 1α,25(OH)2D3 inhibits macrophage production of IL-12 [26], decreases lymphoproliferation 
and production of IFN-γ and IL-2 from Th1 cells [2,27,28]. The resulting Th2 relative dominance has 
been used as an explanation for the earlier observation (1990’s) that the rise in allergic disease 
coincided with the introduction of routine vitamin D fortification in high latitude regions [16,17]. 
However, just as with the epidemiological associations, the effects of vitamin D on Th2 cells have also 
been contradictory, with reports of both enhancement and inhibition [29,30].  
In animal models, an increased Th2 response to vitamin D has been accompanied by increase in 
anti-inflammatory IL-10 response [30]. In human studies there is some evidence of a non-linear 
response to vitamin D, in that both high and low levels have been associated with increased Th2 
activity, but also evidence of an increased regulatory response. Accordingly, there is increasing 
evidence that the immunomodulatory effect of vitamin D may act not only through modulation of 
helper T cell function, but also through induction of CD4+CD25+ regulatory T cells (Tregs) [29]. This 
may be one possible explanation for the epidemiological links between both autoimmune disease and 
allergy with vitamin D deficiency [31].  
Tregs include a diverse range of cells that appear to exert their effect variously through inhibiting 
transcription of the inflammatory cytokine IL-2, expressing IL-10, and potentially converting effector 
T cells to hyporesponsive or regulatory forms [30,32]. One of the factors shown to enhance Treg 
proliferation is the presence of the active form of vitamin D, 1α,25(OH)2D3, which binds to the retinoic 
acid receptor of naive T cells, inducing Treg differentiation [30]. To date, the majority of research has 
been conducted using cells sourced from peripheral blood; however some authors have proposed that Nutrients 2012, 4  
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gut-associated lymphoid tissue may be of relevance, particularly in regard to oral vitamin D intake and 
food allergen sensitization [33].  
4.2. Gut-Associated Lymphoid Tissue 
The intestine has evolved a highly specialized immune network to cope with vast exposure to an 
array of foreign antigens (from microbial flora and dietary products) at its luminal surface. This 
network (the GALT) is the largest immune “organ” of the body and comprises distinct tissues (such as 
the Peyer’s patches and mesenteric lymph nodes) as well as a vast array of migrating cells that passage 
through the local tissues (such as DC, B cells, effector T cells and a range of regulatory populations). 
These all act together to provide a finely balanced environment which affords immune defense against 
pathogens while at the same time suppressing unwanted inflammation against harmless commensals 
and allergens [34]. As oral tolerance is arguably one the most critical functions of the GALT, there is 
growing interest in the developmental events in the gut that could contribute to the inappropriate 
immune responses associated with rising rates of food allergy. Given that B and T cells are influenced 
by vitamin D (Section 4.1), there is speculation that orally ingested vitamin D could have the potential 
to directly modulate the function of lymphocytes in the local gut micro-environment. Weiss [33] 
proposes in his editorial on vitamin D and the gut microbiome that vitamin D could potentially interact 
directly with both the GALT and the microflora, to influence immune function and allergy outcomes, a 
theory also explored by Vassallo and Camargo [35]. In this publication the authors speculate that 
compromised antimicrobial production and modulation of host-microbe signaling pathways may alter 
the microbiome and predispose the host to infections. The “vitamin D/microbiome hypothesis” has 
proponents on both sides, with Vassallo and Camargo [35] arguing that deficiency is causative, while 
Wjst [17] suggests that the introduction of vitamin D supplementation coincides with the rise in 
allergic disease. This line of argument highlights that the potency and pharmacokinetics of endogenous 
and exogenous vitamin D may be different and that serum 25(OH)D, sun exposure and oral intake 
should be considered independently of one another. 
4.3. Lung Structure and Function 
In mice, Zosky et al. [4] found that vitamin D deficiency in mice is significantly associated with 
decreased lung volume, tissue volume and increased airway resistance. They proposed that, as reduced 
lung volume is a risk factor for lung function and respiratory illness in humans, vitamin D deficiency 
could increase the risk of these conditions through effects on lung tissue growth. There is some support 
for this in human studies linking vitamin D deficiency with reduced lung function [3,5]. Specifically, 
after adjusting for potential confounding factors (such as body size, gender, smoking history and 
physical activity), Black and Scragg [5] reported a significant association with serum 25(OH)D on 
forced expiratory volume (FEV) and forced vital capacity (FVC). This finding was recently confirmed 
in a Chinese population of newly diagnosed asthmatic adults [3]. The latter study found a high 
prevalence of vitamin D deficiency in patients, with 88.9% of having serum 25(OH)D <50 nmol/L. 
Forced expiratory volume, FEV as a percent of predicted, and FVC were all significantly positively 
correlated with serum 25(OH)D concentration (p < 0.05).  Nutrients 2012, 4  
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The exact physiological mechanisms behind these observations remains unanswered, however there 
is growing evidence of genetic variability that modulates sensitivity to, and effects of, vitamin D 
exposure. It is recognized that 1α,25(OH)2D3 may have a role in regulating activity of a wide number 
of genes, directly and through epigenetic changes including at sites directly related to immune cell 
transcription [36]. 
5. Nuclear Actions, Genetic Polymorphisms and Environmental Interactions 
5.1. Nuclear Actions of Vitamin D 
The vitamin D receptor (VDR), encoded by the VDR gene [37], is a member of the nuclear   
receptor family subgroup NR1I [38]. The VDR mediates its actions by first binding with its ligand 
(1α,25(OH)2D3) then forming a heterodimer with the retinoid X receptor (RXR) [39]. This heterodimer 
binds to the VDR response element (VDRE) and initiates recruitment of nuclear proteins into the 
transcriptional complex [39]. The VDR is found on tissues throughout the body including immune 
cells, with effects on apoptosis and cell differentiation [37]. The DNA-bound VDR/RXR heterodimers 
can also down regulate transcription; such is the case with T cell cytokine production [38]. 
Polymorphisms of the VDR gene could, therefore, have significant effects on immune regulation by 
altering the differentiation and proliferation response [39]. 
5.2. Genetic Polymorphisms in VDR and Other Related Genes 
Mutation to the VDR gene is responsible for conditions such as the rare monogenetic disease   
1,25-dihydroxivitamin D resistant rickets, however many more subtle genetic polymorphisms are 
frequent in the population, although the significance has not been systematically analysed [39]. 
Multiple studies have reported significant association between polymorphisms in the VDR gene with 
asthma as well as a range of autoimmune conditions, although the findings between cohorts have not 
been uniform [37,40,41]. Studies of several major North American cohorts identified a number of 
single nucleotide polymorphisms (SNP) that conferred an increased risk of asthma, including 
ApaI  [37]. Of interest, the ApaI C allele was associated with and increased risk of asthma (over 
represented in asthma cases) from the Nurses’ Health Study (NHS) and a Canadian cohort [37], 
whereas the same allele was protective in the Childhood Asthma Management Program (CAMP) [40]. 
It is possible this discrepancy is influenced by differences in age, atopic risk and gender between study 
populations. In addition to this inconsistence in the direction of risk, other studies have failed to show 
any associations between VDR polymorphisms and asthma or the expression of related allergic 
phenotypes such as eosinophilia and changes in total IgE level [41]. More recently, in a series of genes 
that were albeit weakly associated with allergy phenotypes, VDR polymorphisms were associated with 
both asthma and atopy [42].  
Another gene of interest is VDBP encoding for the vitamin D-binding protein (VDBP). This is 
highly polymorphic (>120 variants) and displays racial and geographic trends. In addition to 
transporting vitamin D in circulation, VDBP has anti-inflammatory and immunomodulatory functions 
including effects on macrophage activation. Polymorphisms that influence the binding affinity and 
immune functions may partly explain the differences in 25(OH)D status and prevalence of certain Nutrients 2012, 4  
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disease (e.g., autoimmune disease, allergy) observed geographically and between individuals of 
different races [43]. In their review on the vitamin D axis in lung disease Chisimba et al. summarise 
inconsistent findings on the relationship of VDBP polymorphisms in the development of asthma, 
although the immunomodulatory role of VDBP makes it a sensible target of further investigation in 
allergic conditions.  
Contradictions and inconsistencies in findings between populations are not uncommon in   
genetic studies, and are likely to reflect the complex, multifactorial and heterogeneic nature of the 
allergic/asthma phenotypes, involving multiple and variable genetic and environmental pathways. 
5.3. Gene-Environment Interactions 
A likely reason that genetic association studies have been largely conflicting and failed to identify 
specific ‘causal’ genes is that the polymorphisms do not necessarily influence risk directly, but may 
more directly reflect the effect of environmental exposures [44]. Some relationships between genotype 
and disease will only be seen in conditions of “high” exposure to an environmental factor of interest, 
whereas others may only be seen in conditions of “low” exposure. Thus, failure to examine the 
relationship in the context of exposure could lead to an inaccurate interpretations or missing potential 
relationships. Similarly, the potential effects of environmental exposures on health outcomes could be 
missed if variations in genetic predisposition are not taken into account. These effects are likely to 
explain inconsistencies between studies looking at the links between genetics and asthma phenotype. 
Functional consequences of VDR polymorphisms may, therefore, vary with the availability of 
vitamin D to tissues and become apparent, or exaggerated, in an environment of vitamin D deficiency, 
such as observed in the case of several infectious diseases [45,46]. Similar complex interactions are 
now recognised with other genes and other environmental exposures in the context of allergic disease, 
including functional genetic polymorphisms that are modified by the effects of microbial exposure [47] 
and cigarette smoke exposure [48]. All of these observations provide further evidence that allergic 
disease has complex multifactorial etiology, with numerous (and diverse) predisposing genes and a 
wide range of interacting environmental factors [44]. The lack of linear associations between many 
functional polymorphisms and disease risk, due to these complex gene-environmental interactions, will 
continue to provide a major challenge in unraveling the pathogenesis of allergic disease. 
6. Pregnancy 
During pregnancy the foetus is exposed to vitamin D through cord blood supply and the ability of 
25(OH)D and 24,25(OH)D to cross the placenta [23]. Maternal vitamin D intake during pregnancy 
(assessed by food frequency questionnaires), is reported to be inversely associated with wheeze [49–51], 
allergic rhinitis and asthma [6]. Miyake et al. found vitamin D to be inversely associated with wheeze 
in Japanese children aged 16–24 months, an association that was no longer significant when adjusted 
for docosahexaenoic acid intake [51]. This reflects the relevance of dietary confounders and the 
differences in intake patterns between populations. In Japan, a major source of dietary vitamin D is 
fish which is a rich source of n-3 fatty acids, whereas other countries such as the US rely heavily on 
vitamin D fortified milk [51] which is relatively high in saturated, and low in polyunsaturated, fatty 
acids [52]. Wheezing is not necessarily indicative of allergic disease as we know that wheeze may be Nutrients 2012, 4  
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induced by viral infection [53]. While vitamin D may be associated with the development of wheeze 
through other mechanisms (see Section 4.3) these reports of wheeze are not necessarily related to a 
true Th2-dominant allergic response. Camargo et al. [49,50] conducted a similar study previous to 
Miyake et al. [51] and have published results of their 2 and 3 year follow-ups. Basing their “recurrent 
wheeze” classification on the Asthma Predictive Index, the authors report a significant inverse 
association between antenatal dietary and supplemental vitamin D intake and the risk of ever having 
wheeze or having recurrent wheeze symptoms. For each 2.5 µg/day (100 IU) incremental increase in 
vitamin D intake the authors found a 10% decrease risk of wheeze and 13% decrease risk of recurrent 
wheeze at 2 years (OR 0.90; 95% CI, 0.83–0.97 and OR 0.87; 95% CI, 0.77–0.97, respectively) and 
similar risk of recurrent wheeze at 3 years of age (OR 0.80; 95% CI 0.72–0.90), adjusted for multiple 
factors. The association remained significant after adjusting for several predisposing risk factors and 
dietary components such as calcium, vitamin E, fish and vegetable intake. However, there was no 
association between maternal vitamin D and eczema risk at 3 years. Similar results have been reported 
by Erkkola et al. [6] who found lower rates of both allergic rhinitis (OR 0.85; 95% CI 0.75–0.96,  
p < 0.01) and asthma (OR 0.80; 95% CI 0.65–0.98, p < 0.05) in 5 year old children with higher 
maternal vitamin D intake in pregnancy, with no relationship to eczema (OR 0.95; 95% CI 0.86–1.05, 
p > 0.05). The cohort studied by Camargo et al. [49,50] involved children at high-risk of asthma and 
allergy, with all participants having eczema themselves or maternal history of asthma. We have found 
similar results to Camargo et al. in terms of eczema outcomes in high-risk infants [54]. There was no 
association between vitamin D intake from diet or supplements during pregnancy, with the risk of 
eczema in infants at 12 months of age. There are several genetic and environmental differences 
between the groups such as the predisposition to type 1 diabetes [6] or allergy [50] and locations 
(Boston, USA [51], Finland [6]) that must be considered when comparing results. However, in general 
dietary/supplemental intake data neglects the contribution of UV radiation to physiological status. For 
this reason serological measures of 25(OH)D may be considered preferable as it reflects the 
combination of endogenous and exogenous sources.  
Gale et al. recorded serum 25(OH)D in addition to dietary and supplemental vitamin D intake and 
estimated UV exposure in 466 pregnant women in the UK [55]. In this cohort 6.5% of women took a 
vitamin D-containing supplement, a factor that was borderline significant for vitamin D status, and 
only 3 women met the UK dietary recommendation of 10 µg/day. UV exposure was more strongly 
related to serum 25(OH)D with a correlation coefficient of 0.60 (p < 0.001). The authors report that the 
risk of atopy was significantly increased in offspring of mothers in the highest quartile of serum 
25(OH)D. Compared to the first quartile, the highest quartile of maternal serum 25(OH)D represented 
an OR of 3.26 (95% CI 1.15–9.29) for eczema at 9 months of age, and 5.40 (95% CI 1.09–26.65) for 
asthma at 9 years. As UV exposure was the dominant factor in 25(OH)D status this paper provides 
different information to those focussing on oral intake. To our knowledge this is the only paper that 
reports such an association between maternal 25(OH)D and atopy. A recent paper by Morales et al. [56] 
involving >1200 Spanish children found no association between maternal serum 25(OH)D during 
pregnancy and wheezing at 1 or 4 years, or asthma at 4–6 years, although the highest quartile of 
maternal serum 25(OH)D was protective of lower respiratory tract infections by age 1 year. Cord 
blood (CB) has been used as a measure of fetal vitamin D status at birth in the investigation of immune 
function and allergic outcomes. However, it is recognized that CB 25(OH)D concentrations are Nutrients 2012, 4  
 
20
consistently lower than maternal levels [23] and may also be lower than infant levels [57]. In a 
longitudinal study from birth to five years Rothers et al. examined CB 25(OH)D in relation to total and 
allergen-specific IgE, sensitization, allergic rhinitis and asthma in a predominantly Caucasian (76.7%) 
population [58]. The authors report that both low (<50 nmol/L) and high (>100 nmol/L) CB 
concentrations were associated with total (coefficient 0.27; 95% CI 0.08–0.47, p = 0.007 and 
coefficient 0.27; 95% CI 0.00–0.54, p = 0.054, respectively) and allergen specific IgE (OR 2.8; 95% 
CI 1.2–6.6, p = 0.02 and OR 3.6; 95% CI 1.2–10.5, p = 0.02, respectively), while high concentration 
was associated with increased risk of sensitisation (OR 3.4; 95% CI 1.0–11.4, p = 0.046). These 
findings are somewhat supported by a Swedish study involving predominantly Caucasian subjects that 
reported CB 25(OH)D to be positively correlated with tolerogenic cytokine IL-10 and a higher ratio of 
IL-10 to IgE [59]. The authors do not report the U-shaped curve observed by Rothers et al. [58] but 
rather a linear correlation of r = 0.21 for serum 25(OH)D and IL-10 [59]. In addition, similar findings 
to that of Rothers et al. [58] have been reported in Caucasian adults, whereby IgE levels were lowest in 
individuals with serum 25(OH)D 100–125 nmol/L but significantly elevated for 25(OH)D concentrations 
<25 nmol/L (OR 1.29; 95% CI 1.09–1.48) and >135 nmol/L (OR 1.56; 95% CI 1.17–1.95) [60]. 
In a seperate population (inner city birth cohort, 71% black, 20% Hispanic, 91% with at least one 
atopic parent) Chi et al. investigated CB 25(OH)D and cytokine responses [61]. This study found no 
significant correlation between CB 25(OH)D and IL-10. Interferon-γ response to LPS were however 
positively correlated with CB 25(OH)D (r = 0.11, p = 0.01), while there appeared to be a negative 
correlation between CB 25(OH)D and the proportion of Treg cells. Recently, genetic traits have been 
identified in African populations that explain part of the predisposition to asthma and the related 
cytokine responses [62]. This adds evidence that genetic variation influences both nuclear and   
non-nuclear actions and helps explain variations in immune function and allergy trends between 
population groups. Genetics and the in utero environment do not tell the whole story of allergy 
development and it is likely that there are distinct postnatal effects that must be considered. 
7. Infancy and Childhood 
The evidence to date suggests that adequate or higher concentrations of 25(OH)D in childhood are 
generally protective of allergic disease [63–65], although not all reports agree [66,67]. So far the main 
focus of those studies has been on respiratory allergic outcomes such as allergic rhinitis, asthma and 
inhalant allergen sensitization. Members of our group have reported lower serum 25(OH)D in Qatari 
children with asthma compared to controls (43.1 ± 27.5 nmol/L and 67.1 ± 24.7 nmol/L, respectively, 
p < 0.001) [65]. In this case-control study serum 25(OH)D <50 nmol/L was the strongest predictor of 
asthma (OR 4.82, p < 0.001) among variables including family history of asthma (OR 2.45, p < 0.001) 
and serum IgE levels (OR 1.98, p = 0.003). Investigating clinical outcomes without immune function 
data, Camargo et al. [67] report a linear relationship between CB 25(OH)D with wheeze at age 
15  months through 5 years and respiratory tract infection at 3 months. The authors report no 
association between CB 25(OH)D and asthma or sensitization. Conducted in Wellington and 
Christchurch, New Zealand, the birth cohort (n = 922) comprised 71% European participants, and 
provides valuable information due to the prospective cohort design, compared to cross-sectional design 
of other studies [64–66]. Cross-sectional studies may be subject to reverse causality, for example, Nutrients 2012, 4  
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where individuals with respiratory conditions such as asthma or allergic rhinitis avoid outdoor 
activities and subsequently receive less UVB exposure.  
In one of the largest cross-sectional studies in the USA (n = 18,224) researchers reported a positive 
association between allergic rhinitis serum 25(OH)D concentration (across quartiles), although there 
were no consistent relationships between 25(OH)D concentration and sensitization to any particular 
allergen [66]. This association was most apparent in younger individuals (<20 years of age) with a 
higher risk of allergic rhinitis in the upper (third and fourth) quartiles of serum 25(OH)D (OR 3.12; 
95% CI 1.11–8.81, p = 0.032, and OR 4.05; 95% CI 1.45–11.28, p = 0.008, respectively). While the 
same relationship was seen in the >20 years age group (for the highest quartile) it was not as strong 
(OR 1.25; 95% CI 1.03–1.53, p = 0.024). 
These findings were not reproduced in a more recent USA population study where the prevalence of 
allergic rhinitis did not vary with 25(OH)D concentration, while there was a protective relationship 
with sensitisation in children and adolescents [64]. Both Wjst and Hyppönen [66] and Sharief et al. [64] 
have well powered studies backed by biological measures and clinical outcome data, however do not 
specifically address early life exposure and are limited by the cross-sectional design. Data is not 
available for neonates or young children and thus may overlook a crucial period in the aetiology of 
allergic disease. The average age for the children/adolescents group in the paper by Sharief et al. [64] 
was 12.5 years, well beyond the critical early period of immune development [68].  
Longitudinally, an Australian study has shown a protective relationship between serum 25(OH)D 
levels at age 6 years and subsequent development of allergic rhinitis at age 14 [63]. In this non-selected 
community cohort there was no relationship between 25(OH)D levels and “current” allergic rhinitis, 
although serum 25(OH)D concentration at 6 years was protective of allergic rhinitis at 14 years   
(OR 0.17; 95% CI 0.05–0.59, p = 0.005). As the majority of asthma is diagnosed by 6 years of age 
these findings do not present relevance to asthma development per se, but possibly on the persistence 
of the condition into adulthood.  
Fewer studies have investigated vitamin D status and food allergy outcomes. The study by   
Sharief et al. [64] found that lower serum 25(OH)D (of ≤37.5 nmol/L) was associated with both peanut 
(OR 2.39; 95% CI 1.29–4.45, p = 0.005) and shrimp (OR 3.08; 95% CI 1.16–8.19, p = 0.02) 
sensitization, however, other studies of food allergy are largely limited to epidemiological data without 
serological measures of vitamin D [69–72]. With the global increase in food allergy globally [11] this 
is a priority area for future research. 
A number of longitudinal observational studies have specifically examined infant vitamin D 
supplementation in the context of allergic disease. This data has the advantage of focussing on the 
early life period and may therefore provide insight into the aetiological role of vitamin D. Despite the 
observed protective association of serum 25(OH)D and allergy, it has been noted that the widespread 
practice of supplementation coincided with the rise in allergic disease [35]. Supporting this observation 
are several studies which found vitamin D supplementation to be associated with an increased risk of 
atopic dermatitis [73], allergic rhinitis [35,74], asthma, sensitisation [69,74] and food allergy [70], 
however none of these papers are supported by biological measures of vitamin D status.   
Hyponnen et al. [74] reported that supplementation with 50 µg vitamin D/day (2000 IU) in the first 
year of life was associated with a higher risk of allergic rhinitis (OR 1.66; 95% CI 1.1–1.6, p < 0.001) 
and atopy (OR 1.46; 95% CI 1.4–2.0, p < 0.001). The dose cited in this paper (50 µg/day or 2000 IU) Nutrients 2012, 4  
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is substantially higher than the 10 µg/day 400 IU recommended for infants today by the American 
Academy of Pediatrics (AAP) [75]. However, other authors investigating infant intakes in this lower 
dose range (closer to AAP recommendations) have also shown that atopic manifestations (particularly 
atopic dermatitis) were more prevalent in children with “high” (>13.1 μg/day) versus “low” 
(≤13.1 μg/day) intake of vitamin D [73]. The increase in relative risk of atopic dermatitis (AD) was 
18% per 1 µg/day increase in vitamin D intake, and a high vitamin D intake was a stronger predictor of 
AD than was family history of atopy. The papers by Bäck et al. [73] and Hyppönen et al. [74] were 
based on Swedish and Finish populations, respectively; countries that share similar environmental 
conditions such as climate and latitude. There is also some evidence that the effect of supplementation 
may depend on whether vitamin D is administered in a fat- or water-soluble form.  
Kull et al. [70] demonstrated that children given vitamin D (400 IU) in water-soluble form during 
the first year of life had an almost two-fold increase in asthma (OR 2.18; 95% CI 1.45–3.28), food 
allergy (OR 1.89; 95% CI 1.33–2.65), and sensitization (OR 1.88; 95% CI 1.34–2.64) at 4 years of age 
compared with children having received the same vitamins in peanut oil (although there was no 
difference in the risk of allergic rhinitis or eczema). These contrasting results highlight the need for 
randomised controlled trials (RCT) to provide clearer picture of role of vitamin D during infancy in 
regulation of allergic disease, including uptake, metabolism and immunomodulation. 
In summary, the contrary epidemiological observations between serum status (generally protective) 
and oral exposure (supplementation increasing allergy risk in many studies) highlight the uncertainty 
surrounding vitamin D in allergy development and precludes population recommendations. Most of 
these observational studies did not have direct serological measures of 25(OH)D levels to accurately 
confirm vitamin D status and cross sectional study designs involving older children and adults fail to 
provide evidence on aetiological factors. Although the significance is not clear, the findings show that 
the timing and route of exposure may play a critical role in immune function. Future research must 
accurately account for the different sources of vitamin D, stage of immune development and genetic 
factors in order to understand the immunological consequences of changing vitamin D status through 
supplementation or lifestyle changes.  
8. Conclusions and Future Directions 
A high percentage of pregnant women globally are known to have 25(OH)D concentrations in the 
insufficient and deficient ranges [22,76,77] yet currently very little information is available on the 
impact of this deficiency on neonatal immune function and subsequent risk of allergic disease. There is 
much evidence to show vitamin D affects differentiation and proliferation of immune cells [2,24,25] 
and that genetic polymorphisms, including of VDR  and  VDBP, may contribute to disease   
susceptibility [42,78–81]. As this early life stage is relevant to programming of future immune 
function it is crucial to understand the effects of vitamin D and identify optimal status levels. Future 
research should differentiate oral intake from endogenous contributions to 25(OH)D status in order to 
clarify the immunological effects of each. Randomized control trials are ultimately required to 
determine the effects of vitamin D supplementation on the developing immune system, and any 
potential role in preventing allergic disease. Nutrients 2012, 4  
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